Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 19, 2019 - Issue 1
Submit an article Journal homepage
897
Views
26
CrossRef citations to date
0
Altmetric
Review

Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis

Daniel WendlingDepartment of Rheumatology, CHRU de BESANCON, University Teaching Hospital, Besançon, France;Université Bourgogne Franche-Comté, Besançon, FranceCorrespondence[email protected]
View further author information
,
Frank VerhoevenDepartment of Rheumatology, CHRU de BESANCON, University Teaching Hospital, Besançon, FranceView further author information
&
Clément PratiDepartment of Rheumatology, CHRU de BESANCON, University Teaching Hospital, Besançon, France;Université Bourgogne Franche-Comté, Besançon, FranceView further author information
Pages 55-64 | Received 17 Oct 2018, Accepted 27 Nov 2018, Published online: 07 Dec 2018

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Fabiola Atzeni, Antonio Carriero, Laura Boccassini & Salvatore D’Angelo. (2021) Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis. ImmunoTargets and Therapy 10, pages 141-153.
Read now
Daniel Wendling & Philippe Goupille. (2020) From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibition. Expert Opinion on Biological Therapy 20:8, pages 837-840.
Read now
Sebastian Spindeldreher, Anette Karle, Evelyne Correia, Maxime Tenon, Sascha Gottlieb, Thomas Huber, Bernard Maillere & Frank Kolbinger. (2020) T cell epitope mapping of secukinumab and ixekizumab in healthy donors. mAbs 12:1.
Read now

Articles from other publishers (23)

Philippe Goupille & Daniel Wendling. (2024) Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?. Joint Bone Spine 91:3, pages 105662.
Crossref
Fangzhou Li, Jiang Ouyang, Zuqin Chen, Ziran Zhou, Julien Milon Essola, Barkat Ali, Xinyue Wu, Mengliang Zhu, Weisheng Guo & Xing‐Jie Liang. (2023) Nanomedicine for T‐Cell Mediated Immunotherapy. Advanced Materials.
Crossref
Saeideh Sadat Shobeiri, Kazem Mashayekhi, Motahareh Khorrami, Malihe Moghadam & Mojtaba Sankian. (2022) Selection and characterization of a new human Interleukin-17A blocking DNA aptamer using protein-SELEX. Biochemical and Biophysical Research Communications 637, pages 32-39.
Crossref
Ruth Rodríguez-Montaño, Alondra del Carmen Ruiz-Gutiérrez, Vianeth María del Carmen Martínez-Rodríguez, Juan Ramón Gómez-Sandoval, Juan Manuel Guzmán-Flores, Julieta Sarai Becerra-Ruiz, Ana Lourdes Zamora-Perez & Celia Guerrero-Velázquez. (2022) Levels of IL-23/IL-17 Axis in Plasma and Gingival Tissue of Periodontitis Patients According to the New Classification. Applied Sciences 12:16, pages 8051.
Crossref
Ruoyang Feng, Mengnan Lu, Lin Liu, Ke Xu & Peng Xu. (2022) Transcriptome-Wide Association Studies and Integration Analysis of mRNA Expression Profiles Identify Candidate Genes and Pathways Associated With Ankylosing Spondylitis. Frontiers in Immunology 13.
Crossref
Daniel Wendling, Sophie Hecquet, Olivier Fogel, Jean-Guillaume Letarouilly, Frank Verhoeven, Thao Pham, Clément Prati, Anna Molto, Philippe Goupille, Emmanuelle Dernis, Alain Saraux, Adeline Ruyssen-Witrand, Cédric Lukas, Corinne Miceli-Richard, Christophe Hudry, Pascal Richette, Maxime Breban, Laure Gossec, Maxime Dougados & Pascal Claudepierre. (2022) Actualisation 2022 des recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite, incluant le rhumatisme psoriasique. Revue du Rhumatisme 89:3, pages 210-222.
Crossref
Daniel Wendling, Sophie Hecquet, Olivier Fogel, Jean-Guillaume Letarouilly, Frank Verhoeven, Thao Pham, Clément Prati, Anna Molto, Philippe Goupille, Emmanuelle Dernis, Alain Saraux, Adeline Ruyssen-Witrand, Cédric Lukas, Corinne Miceli-Richard, Christophe Hudry, Pascal Richette, Maxime Breban, Laure Gossec, Maxime Dougados & Pascal Claudepierre. (2022) 2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis. Joint Bone Spine 89:3, pages 105344.
Crossref
Jing Lu, Long Xie, Kai Liu, Xuming Zhang, Xian Wang, Xiaolin Dai, Youdan Liang, Yi Cao & Xiaofang Li. (2021) Bilobalide: A review of its pharmacology, pharmacokinetics, toxicity, and safety. Phytotherapy Research 35:11, pages 6114-6130.
Crossref
Mengjun Ma, Hongyu Li, Peng Wang, Wen Yang, Rujia Mi, Jiahao Zhuang, Yuhang Jiang, Yixuan Lu, Xin Shen, Yanfeng Wu & Huiyong Shen. (2021) ATF6 aggravates angiogenesis-osteogenesis coupling during ankylosing spondylitis by mediating FGF2 expression in chondrocytes. iScience 24:7, pages 102791.
Crossref
Philippe Goupille & Daniel Wendling. (2021) Vers une prise en charge personnalisée des patients atteints de spondyloarthrite axiale ?. Revue du Rhumatisme 88:3, pages 169-172.
Crossref
Zhan‐Peng Ge, Yao‐Yue Fan, Wen‐De Deng, Cheng‐Yu Zheng, Ting Li & Jian‐Min Yue. (2021) Cephalodiones A–D: Compound Characterization and Semisynthesis by [6+6] Cycloaddition. Angewandte Chemie International Edition 60:17, pages 9374-9378.
Crossref
Zhan‐Peng Ge, Yao‐Yue Fan, Wen‐De Deng, Cheng‐Yu Zheng, Ting Li & Jian‐Min Yue. (2021) Cephalodiones A–D: Compound Characterization and Semisynthesis by [6+6] Cycloaddition. Angewandte Chemie 133:17, pages 9460-9464.
Crossref
Philippe Goupille & Daniel Wendling. (2021) Toward a tailored therapeutic prescription for patients with axial spondyloarthritis. Joint Bone Spine 88:2, pages 105019.
Crossref
Claudia Schinocca, Chiara Rizzo, Serena Fasano, Giulia Grasso, Lidia La Barbera, Francesco Ciccia & Giuliana Guggino. (2021) Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview. Frontiers in Immunology 12.
Crossref
Tobias Russell, Abdulla Watad, Charlie Bridgewood, Hannah Rowe, Almas Khan, Abhay Rao, Peter Loughenbury, Peter Millner, Robert Dunsmuir, Richard Cuthbert, Ala Altaie, Elena Jones & Dennis McGonagle. (2021) IL-17A and TNF Modulate Normal Human Spinal Entheseal Bone and Soft Tissue Mesenchymal Stem Cell Osteogenesis, Adipogenesis, and Stromal Function. Cells 10:2, pages 341.
Crossref
Yufeng Yin, Mingjun Wang, Mengru Liu, Erye Zhou, Tian Ren, Xin Chang, Michun He, Keqin Zeng, Yufan Guo & Jian Wu. (2020) Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Research & Therapy 22:1.
Crossref
Hiroyuki Tsukazaki & Takashi Kaito. (2020) The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis. International Journal of Molecular Sciences 21:17, pages 6401.
Crossref
Marine Fauny, David Moulin, Ferdinando D'Amico, Patrick Netter, Nadine Petitpain, Djesia Arnone, Jean-Yves Jouzeau, Damien Loeuille & Laurent Peyrin-Biroulet. (2020) Paradoxical gastrointestinal effects of interleukin-17 blockers. Annals of the Rheumatic Diseases 79:9, pages 1132-1138.
Crossref
Daniel Wendling & Philippe Goupille. (2020) Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis. Immunotherapy 12:12, pages 857-860.
Crossref
Senol Kobak. (2020) Secukinumab-induced Raynaud’s phenomenon: first report in the literature. Therapeutic Advances in Drug Safety 11, pages 204209862090597.
Crossref
Daniel Wendling, Clément Prati, Mickael Chouk & Frank Verhoeven. (2020) Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism?. Joint Bone Spine 87:1, pages 5-7.
Crossref
Young Hun Chung, Hui Cai & Nicole F. Steinmetz. (2020) Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications. Advanced Drug Delivery Reviews 156, pages 214-235.
Crossref
Daniel Wendling. (2019) New targeted therapies in spondyloarthritis: what are the limits?. Immunotherapy 11:7, pages 557-560.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.